AbbVie Inc. is a global, research-based biopharmaceutical company that discovers, develops, and commercializes advanced therapies. Spun off from Abbott Laboratories in 2013, the company focuses on key therapeutic areas including immunology, oncology, neuroscience, and aesthetics. It is known for its biologic drugs such as Humira, Skyrizi, and Rinvoq, as well as its Botox franchise.
In 2025, three wholesale distributors -- McKesson Corporation, Cardinal Health, Inc. and Cencora, Inc. -- accounted for substantially all of AbbVie's pharmaceutical product sales in the United States. No individual wholesaler accounted for greater than 43% of AbbVie's 2025 gross revenues in the U.S. AbbVie states it has no single customer that, if lost, would have a material adverse effect on its business.